Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gila Hale
Institutions:
London School of Hygiene & Tropical Medicine,
Infectious Diseases Institute,
Makerere University
Observed institutions:
University of Minnesota,
University of Kansas,
London School of Hygiene & Tropical Medicine,
Infectious Diseases Institute,
Makerere University
ORCID:
0009-0009-2705-108X
Observed ORCID:
0009-0009-2705-108X
OpenAlex ID:
A5105876909
Works
9
Awards
1
Systematic Review of Prevalence of Histoplasma Antigenuria in Persons with HIV in Latin America and Africa
2024
·
Preethiya Sekar
, Gila Hale
, et al.
·
Emerging infectious diseases
·
15
PDF
Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease
2025
·
Jayne Ellis
, Biyue Dai
, et al.
·
AIDS
·
7
Integrated management of cryptococcal meningitis and concurrent opportunistic infections to improve outcomes in advanced HIV disease: a randomised strategy trial
2024
·
Jayne Ellis
, Laura Nsangi
, et al.
·
Wellcome Open Research
·
7
Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trial
2026
·
Jayne Ellis
, Gila Hale
, et al.
·
The Lancet HIV
·
6
Adequacy of recommendations for adverse event management in national and international treatment guidelines for rifampicin-susceptible tuberculosis: a systematic review
2025
·
William Burman
, Jayne Ellis
, et al.
·
EClinicalMedicine
·
5
Mid–Upper Arm Circumference Is a Strong Predictor of Mortality Among Ugandan Adults With HIV-Associated Cryptococcal Meningitis: A Prospective Cohort Study
2024
·
Gila Hale
, Tessa Adzemovic
, et al.
·
Open Forum Infectious Diseases
·
4
Once-Daily Dolutegravir–Based Antiretroviral Therapy Among Adults With Advanced HIV Disease Receiving 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis-Preventive Therapy and Fluconazole for Treatment of Cryptococcal Meningitis: Results of a Pharmacokinetic Study
2026
·
Jayne Ellis
, Gila Hale
, et al.
·
Open Forum Infectious Diseases
Balancing Protocol Requirements with Patient Autonomy: A Case Study on Post-Randomization Refusal in an HIV related clinical trial
2026
·
Olivie Carolyne Namuju
, Provia Ainembabazi
, et al.
·
Research Square
PDF
Prevalence of CSF HIV VIRAL Escape and Associations With Neurocognitive Outcomes Among HIV-Associated Meningitis Survivors: A Cohort Study
2026
·
Laura Nsangi
, Gila Hale
, et al.
·
Open Forum Infectious Diseases
Show more works
View as search
Works count:
9
Citation count:
44
H-index:
5
I10-index:
1
Year
Topic
Type